Winslow Capital Management
ABMD

Winslow Capital Management’s Abiomed Inc ABMD Stock Holding History

Winslow Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,251,859
Closed -$308M – 59
2022
Q3 		$308M Sell
1,251,859
-25,734
-2% -$6.95M 1.8% 27
2022
Q2 		$316M Buy
1,277,593
+373,057
+41% +$101M 1.69% 30
2022
Q1 		$300M Buy
+904,536
New +$278M 1.3% 32
2019
Q1 		– Sell
-523,751
Closed -$170M – 100
2018
Q4 		$170M Buy
523,751
+523,636
+455,336% +$182M 1.06% 44
2018
Q3 		$52K Sell
115
-208
-64% -$82K ﹤0.01% 69
2018
Q2 		$132K Sell
323
-784,769
-100% -$284M ﹤0.01% 63
2018
Q1 		$228M Buy
+785,092
New +$199M 1.24% 42

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Winslow Capital Management's ABMD Position: Q4 2022 in Review

Winslow Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,251,859 shares — an estimated $308M sold.

Winslow Capital Management first reported a position in ABMD in Q1 2018 and held it in 7 quarters. The position peaked at $316M in Q2 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Winslow Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Winslow Capital Management sold 1,251,859 Abiomed Inc shares in Q4 2022, an estimated $308M.
  • Winslow Capital Management first reported a position in Abiomed Inc in Q1 2018 and held it in 7 quarters.
  • Winslow Capital Management's Abiomed Inc position peaked at $316M in Q2 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Winslow Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.